Cangene Corporation

FRA:YGE (Canada)  
€ 2.34 (0%) Dec 31
At Loss
Market Cap:
€ 152.18M ($ 161.72M)
Enterprise V:
€ 152.18M ($ 161.72M)
Volume:
-
Avg Vol (2M):
-

Business Description

Description
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Financial Strength

Name Current Vs Industry Vs History
Interest Coverage No Debt

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % 6.23

GF Value Rank

Name Current Vs Industry Vs History

Financials

FRA:YGE's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cangene Corporation Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 87.29
EPS (TTM) (€) -0.093
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR (€) 0
20-Day SMA (€) 0
12-1 Month Momentum % 0
52-Week Range (€) 0 - 2.4
Shares Outstanding (Mil)

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cangene Corporation Filings

Filing Date Document Date Form
No Filing Data

Cangene Corporation Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Cangene Corporation Frequently Asked Questions

What is Cangene Corporation(FRA:YGE)'s stock price today?
The current price of FRA:YGE is €2.34. The 52 week high of FRA:YGE is €2.40 and 52 week low is €0.00.
When is next earnings date of Cangene Corporation(FRA:YGE)?
The next earnings date of Cangene Corporation(FRA:YGE) is .
Does Cangene Corporation(FRA:YGE) pay dividends? If so, how much?
Cangene Corporation(FRA:YGE) does not pay dividend.

Press Release

Subject Date
No Press Release